Greenfield, WI, United States of America

James B Antczak

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James B Antczak. Retrieved from https://idiyas.com/inventor/james-b-antczak-i3u6au1f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James B Antczak: Innovator in Respiratory Disease Treatment

Introduction

James B Antczak is a notable inventor based in Greenfield, WI (US). He has made significant contributions to the field of medicine, particularly in the treatment of respiratory diseases. His innovative approach focuses on reducing the amount of active leukotriene B (LTB) to treat or prevent diseases in both humans and non-human animals.

Latest Patents

James B Antczak holds 1 patent that describes methods and uses for treating or preventing diseases by utilizing LTB hydroxylases. This patent outlines the administration of LTB hydroxylase in combination with nicotinamide adenine dinucleotide phosphate and/or an NADPH-cytochrome P-450 reductase. The invention is particularly beneficial for addressing respiratory diseases that are caused or exacerbated by inflammation.

Career Highlights

Throughout his career, Antczak has demonstrated a commitment to advancing medical treatments. His work has the potential to improve the quality of life for many individuals suffering from respiratory conditions.

Collaborations

James B Antczak has collaborated with notable colleagues, including David R Harder and Lane Brostrom. Their combined expertise contributes to the innovative solutions being developed in the field of respiratory disease treatment.

Conclusion

James B Antczak is a pioneering inventor whose work in reducing leukotriene B levels offers promising advancements in the treatment of respiratory diseases. His contributions are vital to the ongoing efforts in medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…